NCT03498573

Brief Summary

patients suffering from anterior maxillary horizontal bone defect the alveolar ridge will be augmented by minimally invasive tunneling technique utilizing MPM as bone graft and patients followed up for 14 weeks .

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 13, 2018

Completed
18 days until next milestone

Study Start

First participant enrolled

May 1, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

April 13, 2018

Status Verified

April 1, 2018

Enrollment Period

2 months

First QC Date

March 29, 2018

Last Update Submit

April 7, 2018

Conditions

Bone Atrophy

Outcome Measures

Primary Outcomes (1)

  • bone formation

    bone formation assessed by cone beam ct

    14 weeks

Study Arms (1)

tunneling surgical technique

EXPERIMENTAL
Other: tunneling surgical technique

Interventions

tunneling surgical techniqueOTHER

sticky bone prepared by centrifuge patient blood and mixing with xinograft

Also known as: mpm
tunneling surgical technique

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients' age range from 18-60 years.
  • Patients with horizontal bone defect in anterior maxillary area.
  • Patients should be free from any systemic disease that may affect normal healing of bone and predictable outcome.

You may not qualify if:

  • Patients with systemic diseases as history of radiation therapy or chemotherapy, hematological disorders and autoimmune diseases (may affect normal healing).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Nevins ML, Camelo M, Nevins M, Schupbach P, Friedland B, Camelo JM, Kim DM. Minimally invasive alveolar ridge augmentation procedure (tunneling technique) using rhPDGF-BB in combination with three matrices: a case series. Int J Periodontics Restorative Dent. 2009 Aug;29(4):371-83.

    PMID: 19639058BACKGROUND

MeSH Terms

Interventions

1-methyl-1-piperidinomethane sulfonate

Central Study Contacts

hussien amer elkady, B.D.S

CONTACT

01141178095elkady_003@yahoo.com

tarek elghareeb

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
dentist

Study Record Dates

First Submitted

March 29, 2018

First Posted

April 13, 2018

Study Start

May 1, 2018

Primary Completion

July 1, 2018

Study Completion

April 1, 2019

Last Updated

April 13, 2018

Record last verified: 2018-04